Latest Financial Management News

Melbana Energy advances its Cuban Block 9 operations with the Alameda-2 workover and prepares to drill Amistad-2, while announcing maiden resource estimates offshore Western Australia’s AC/P70 permit.

Sheffield Resources delivered a standout quarter with record mineral sands shipments and positive operating cashflow from its Thunderbird Mine joint venture, setting the stage for a significant production increase by 2027.

Far Northern Resources has amended its December 2024 Appendix 5B cash flow report to provide clearer details on investing activities, revealing a net cash outflow and a modest cash balance at quarter-end.

NeuRizer Ltd has completed a $200,000 private share placement, issuing over 133 million new shares to support working capital and advance its Urea Project.

Burgundy Diamond Mines has secured a novel diesel fuel offtake agreement with Macquarie Bank, easing seasonal cash flow pressures and potentially setting a precedent for multi-year collaboration.

Westpac’s 1Q25 update reveals a resilient $1.7 billion net profit and strong loan growth despite margin pressures and economic headwinds.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Treasury Wine Estates has delivered a robust half-year performance with revenue climbing nearly 20% and profit surging 33%, driven by premiumisation and strategic acquisitions. The company also declared a higher interim dividend, signaling confidence in its growth trajectory.

New Zealand Coastal Seafoods reports a sharp reduction in losses following the closure of its New Zealand operations and reveals promising initial fishing results in the Coral Sea. The company is actively exploring commercial opportunities for its Coral Sea Fishery permits and a potential acquisition to boost future revenues.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

Seven West Media reported a 6% decline in total TV advertising revenue for the half-year ending December 2024 but achieved record digital audience growth and increased its TV revenue share to 41.5%. The company’s strategic investments in digital platforms and cost management signal a pivot towards a more resilient media business.